T. Rowe Price Associates’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Hold |
17,211
| – | – | ﹤0.01% | 2940 |
|
|
2025
Q1 | $77K | Buy |
17,211
+3,144
| +22% | +$14.1K | ﹤0.01% | 2872 |
|
|
2024
Q4 | $111K | Sell |
14,067
-8,470
| -38% | -$66.8K | ﹤0.01% | 2808 |
|
|
2024
Q3 | $297K | Buy |
22,537
+258
| +1% | +$3.4K | ﹤0.01% | 2481 |
|
|
2024
Q2 | $270K | Buy |
22,279
+1,121
| +5% | +$13.6K | ﹤0.01% | 2463 |
|
|
2024
Q1 | $345K | Buy |
21,158
+1,657
| +8% | +$27K | ﹤0.01% | 2370 |
|
|
2023
Q4 | $133K | Buy |
19,501
+1,219
| +7% | +$8.31K | ﹤0.01% | 2658 |
|
|
2023
Q3 | $100K | Hold |
18,282
| – | – | ﹤0.01% | 2668 |
|
|
2023
Q2 | $125K | Sell |
18,282
-6,441
| -26% | -$44K | ﹤0.01% | 2644 |
|
|
2023
Q1 | $124K | Buy |
24,723
+7,100
| +40% | +$35.6K | ﹤0.01% | 2641 |
|
|
2022
Q4 | $86K | Buy |
17,623
+915
| +5% | +$4.47K | ﹤0.01% | 2742 |
|
|
2022
Q3 | $241K | Buy |
16,708
+2,285
| +16% | +$33K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $218K | Buy |
14,423
+258
| +2% | +$3.9K | ﹤0.01% | 2561 |
|
|
2022
Q1 | $168K | Buy |
+14,165
| New | +$168K | ﹤0.01% | 2743 |
|
|
2019
Q4 | – | Sell |
-837,800
| Closed | -$21.8M | – | 2550 |
|
|
2019
Q3 | $21.8M | Buy |
837,800
+89,449
| +12% | +$2.33M | ﹤0.01% | 1117 |
|
|
2019
Q2 | $17.1M | Buy |
748,351
+108,054
| +17% | +$2.47M | ﹤0.01% | 1218 |
|
|
2019
Q1 | $16.8M | Buy |
640,297
+250,800
| +64% | +$6.57M | ﹤0.01% | 1227 |
|
|
2018
Q4 | $7.92M | Buy |
389,497
+97
| +0% | +$1.97K | ﹤0.01% | 1343 |
|
|
2018
Q3 | $10.3M | Buy |
+389,400
| New | +$10.3M | ﹤0.01% | 1365 |
|